Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
This is a double-blind, placebo-controlled, parallel group study designed to assess the tolerability and efficacy of fsCBD and bsCBD, compared to a placebo control, to improve cognition and traumatic brain injury-related symptoms. If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.
If eligible for the study, subjects will be randomized to receive one of the conditions for 12 weeks.
Adult
Treatment
Local
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital
Kent Hutchison, PhD
Protocol Number: 22-1427
More information available at ClinicalTrials.gov: NCT05632627
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers